T 0813/19 (Anti-activin A antibodies/AMGEN) of 07.07.2022

European Case Law Identifier: ECLI:EP:BA:2022:T081319.20220707
Date of decision: 7 July 2022
Case number: T 0813/19
Petition for review of: -
Application number: 12154124.7
IPC class: A61P 9/10 C12N 15/13 A61P 43/00 A61P 37/00 A61P 35/00 A61P 5/06 A61K 39/395 C07K 16/22
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: Anti-activin A antibodies and uses thereof
Applicant name: Amgen Inc.
Opponent name: Regeneron Pharmaceuticals, Inc.
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 111(1)European Patent Convention Art 113(1)European Patent Convention Art 56 European Patent Convention R 106
Keywords: Inventive step - (no)
Obligation to raise objections - objection dismissed
Catchword: -
Cited cases: R 0001/08 R 0013/09
Citing cases: -

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.